Clinical Trial

68Ga-MY6349 PET/CT in Solid Tumors

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to construct a noninvasive approach 68Ga-MY6349 PET/CT to detect the Trop-2 expression of tumor lesions in patients with solid tumors and to identify patients benefiting from Trop-2 PET/CT.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-23.
Trial Details
NCT Number NCT07046702
Lead Sponsor The First Affiliated Hospital of Xiamen University
Conditions Solid Tumor, Trop2, PET/CT
Enrollment 300 participants
Start Date 2024-12-10
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-15